Interested in the latest updates from Bayer?
From products and programs to events and support resources, there's always something new to learn from Bayer. Allow us to provide the latest information right in your inbox so you never miss a beat.
From products and programs to events and support resources, there's always something new to learn from Bayer. Allow us to provide the latest information right in your inbox so you never miss a beat.
JIVI®, KOVALTRY®, and KOGENATE® FS are injectable medicines used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A.
JIVI is used to treat and control bleeding in previously treated adults and adolescents (12 years of age and older) with hemophilia A. Your healthcare provider may also give you Jivi when you have surgery. JIVI can reduce the number of bleeding episodes in adults and adolescents with hemophilia A when used regularly (prophylaxis).
JIVI is not for use in children below 12 years of age or in previously untreated patients.
KOVALTRY is used to treat and control bleeding in adults and children with hemophilia A. KOVALTRY can reduce the number of bleeding episodes in adults and children with hemophilia A when used regularly (prophylaxis). Your healthcare provider may give you KOVALTRY when you have surgery.
KOGENATE FS is used to treat and control bleeding in adults and children with hemophilia A. Your healthcare provider may give you KOGENATE FS when you have surgery. KOGENATE FS can reduce the number of bleeding episodes in adults and children when used regularly (prophylaxis). KOGENATE FS can reduce the risk of joint damage in children without pre-existing joint damage when used regularly.
JIVI, KOVALTRY, and KOGENATE FS are not indicated for the treatment of von Willebrand disease.
For additional important risk and use information, please see full Prescribing Information for Jivi, Kovaltry and Kogenate FS.